A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine

European Journal of Pharmacology
Yoriko MiyashitaToshihide Nukada

Abstract

Amlodipine, a dihydropyridine derivative, has been shown to block not only L-type but also N-type Ca(2+) channels. Aiming to understand the mechanism underlying such a selective blockade by amlodipine, the interaction of amlodipine with N-type channels was investigated using the Xenopus oocyte expression system together with the two-microelectrode voltage-clamp technique and the binding assay for [(3)H]amlodipine. When expressed as the alpha(1B)alpha(2/)delta(1)beta(1a) combination, the N-type channel formed a high affinity binding site for [(3)H]amlodipine (K(d), 3.08nM) and was profoundly blocked by amlodipine (IC(50), 2.7 microM at -60mV). By contrast, R-type (alpha(1E)alpha(2/)delta(1)beta(1a)) channels did not possess a high affinity binding site for [(3)H]amlodipine and their channel activities were not influenced by amlodipine. In comparison of amino acid sequences in the transmembrane regions IIIS5, IIIS6 and IVS6 of the alpha(1) subunit, which are involved in dihydropyridine binding in L-type channels, the two amino acid residues Lys(1287) (corresponding to Met(1295) in alpha1B) and Phe(1699) (corresponding to Leu(1697) in alpha(1B)) were unique in alpha(1E). An amino acid substitution of Lys1287Met in IIIS5 of alpha(1...Continue Reading

References

Sep 1, 1991·Trends in Pharmacological Sciences·R W TsienW A Horne
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·G P Miljanich, J Ramachandran
May 1, 1993·British Journal of Pharmacology·A D Hughes, S Wijetunge
Oct 4, 1996·The Journal of Biological Chemistry·S HeringH Glossmann
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·G H HockermanW A Catterall
Apr 16, 1998·Trends in Genetics : TIG·J L Doyle, L Stubbs
Jun 5, 1998·Trends in Pharmacological Sciences·R A OphoffM D Ferrari
Dec 16, 1998·Trends in Pharmacological Sciences·S HeringE N Timin
Aug 14, 1999·Nucleic Acids Research·P O AngrandA F Stewart
Sep 1, 2005·The Journal of General Physiology·Xiao-Guang ZhenJian Yang
May 7, 2009·The Journal of Biological Chemistry·Denis B Tikhonov, Boris S Zhorov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.